IMA
ImageneBio Inc
1W: -2.0%
1M: -13.6%
3M: -7.2%
YTD: -14.3%
1Y: -62.9%
3Y: -88.7%
$5.69
+0.00 (+0.00%)
After Hours: $5.09 (-0.60, -10.54%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$63.6M
52W Range5.48-18
Volume47,248
Avg Volume43,130
Beta0.45
Dividend—
Analyst Ratings
Company Info
CEOKristin Yarema
Employees10
SectorHealthcare
IndustryBiotechnology
IPO Date1998-02-27
Websiteinmagenebio.com
12526 High Bluff Drive, Suite 345, San Diego, CA 92130
San Diego, CA 92130
US
San Diego, CA 92130
US
858 345 6265
About ImageneBio Inc
Clinical-stage biotechnology company developing differentiated therapies for immunological/autoimmune & inflammatory (I&I) diseases, notably non‑depleting anti‑OX40 monoclonal antibody IMG‑007 in Phase 2b for atopic dermatitis
Latest News
Akeso Announces Global First-in-Class Trispecific Antibody AK150 Enters Clinical Trials: A Triple-Target Approach to Overcome Immunotherapy Resistance
Atlas Venture Life Science Advisors LLC Buys New Position in ImageneBio, Inc. $IMA
Baird Medical Expands Global Reach with Regulatory Clearance in Argentina
ImageneBio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Company Update
ImageneBio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Company Update
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Porter-Brown Benjami | 0 | — | 2026-02-16 | |
| Butler Erin | A-Award | 22,500 | — | 2025-12-30 |
| Butler Erin | A-Award | 22,500 | $7.11 | 2025-12-30 |
| Wang Jonathan Jian | A-Award | 31,200 | $6.19 | 2025-12-18 |
| Wang Stephen Hui | A-Award | 31,200 | $6.19 | 2025-12-18 |